Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 309.00
+5.90 (1.95%)
Apr 28, 2026, 4:59 PM CET
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 21.82 billion as of April 28, 2026. Its market cap has decreased by -24.77% in one year.
Market Cap
21.82B
Enterprise Value
7.12B
Revenue
9.21B
Ranking
n/a
PE Ratio
3.42
Stock Price
309.00
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 21.82B, an increase of 1,452.29%. That is a compound annual growth rate of 19.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 21.82B | -33.58% |
| Dec 30, 2025 | 32.85B | -35.01% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.15T |
| Genmab | 105.04B |
| Coloplast | 93.02B |
| ALK-Abelló | 50.03B |
| Demant | 43.28B |
| H. Lundbeck | 42.17B |
| Ambu A/S | 17.24B |
| Bavarian Nordic | 14.31B |